Skip to main content

Table 2 Fracture events of patients who completed the 18-months study duration

From: Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates

Study period of TPTD administration

−18 ~ −13 months

−12 ~ −7 months

−6 ~ 0 months

0 ~ 6 months

7 ~ 12 months

13 ~ 18 months

Patients

0

1

6

0

0

1

Fracture events

0

1

7

0

0

1

  1. This table shows the number of total fracture events and patients with new fractures before or after TPTD administration